Monoclonal Antibodies for Cancer Immunotherapy
- 25 September 2020
- book chapter
- other
- Published by Springer Science and Business Media LLC
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Phase II trial of hu14.18-IL2 for patients with metastatic melanomaCancer Immunology, Immunotherapy, 2012
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysisThe Lancet Oncology, 2010
- Chemotherapy and radiotherapy: Cryptic anticancer vaccinesSeminars in Immunology, 2010
- Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancyLeukemia Research, 2009
- Analytical methods for inferring functional effects of single base pair substitutions in human cancersHuman Genetics, 2009
- Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancerCancer Immunology, Immunotherapy, 2008
- Recent advances in the generation of human monoclonal antibodyCytotechnology, 2007
- Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complexCancer Cell, 2004
- Phage antibodies: filamentous phage displaying antibody variable domainsNature, 1990
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986